Hydrocortisone in the management of dengue shock syndrome.
Southeast Asian J Trop Med Public Health
;
1975 Dec; 6(4): 573-9
Artículo
en Inglés
| IMSEAR
| ID: sea-35462
ABSTRACT
A total of 98 patients with dengue shock syndrome admitted into Children's Hospital from February 1973 to February 1974 were randomly selected into 2 groups. A double blind controlled trial of the efficacy of pharmacologic doses of hydrocortisone hemisuccinate was carried out. The 2 groups were confirmed to be completely matched by age, sex and severity of the disease. Nine deaths occurred out of 48 cases in the steroid group (Case Fatality Rate 18.75%) and 22 deaths out of 50 cases in the non-steroid group (Case Fatality Rate 44%), the difference being statistically significant. No significant difference was detected in fluid requirements and other morbidity pattern.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Choque Hemorrágico
/
Presión Sanguínea
/
Humanos
/
Esquema de Medicación
/
Hidrocortisona
/
Niño
/
Preescolar
/
Mianmar
/
Dengue
/
Evaluación de Medicamentos
Tipo de estudio:
Ensayo Clínico Controlado
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Southeast Asian J Trop Med Public Health
Año:
1975
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS